Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
6.49
-0.36 (-5.26%)
At close: May 9, 2025, 4:00 PM
7.00
+0.51 (7.86%)
After-hours: May 9, 2025, 7:38 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $22.71 million as of May 9, 2025. Its market cap has decreased by -70.29% in one year.
Market Cap
22.71M
Enterprise Value
7.80M
1-Year Change
-70.29%
Ranking
Category
Stock Price
$6.49
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $22.71M, a decrease of -74.39%. That is a compound annual growth rate of -29.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 22.71M | -37.65% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |